Concepedia

Gary J. Doherty

GJ

Statistics

Publications

28

Citations

2.8K

H-Index

22

Active since

2008

Affiliations

Cambridge University Hospitals NHS Foundation Trust(Current)

The University of Texas MD Anderson Cancer Center

AstraZeneca (United Kingdom)

University of Cambridge

Duke Medical Center

Gary J. Doherty is an author at Cambridge University Hospitals NHS Foundation Trust specializing in oncology, medicine, and life sciences.

ORCID

Publications per year

2008–2025

28

Publications

28

Perioperative Durvalumab for Resectable Non–Small-Cell Lung Cancer

John V. Heymach, David H. Harpole, Tetsuya Mitsudomi et al. · New England Journal of Medicine · 2023 · 682 citations · Full text

, , +17

Galacto‐conjugation of Navitoclax as an efficient strategy to increase senolytic specificity and reduce platelet toxicity

Estela González‐Gualda, Marta Pàez‐Ribes, Beatriz Lozano‐Torres et al. · Aging Cell · 2020 · 274 citations · Full text

, , +13

The GTPase-Activating Protein GRAF1 Regulates the CLIC/GEEC Endocytic Pathway

Richard Lundmark, Gary J. Doherty, Mark T. Howes et al. · Current Biology · 2008 · 252 citations · Full text

, , +17

Clearance of senescent macrophages ameliorates tumorigenesis in KRAS-driven lung cancer

Scott Haston, Estela González‐Gualda, Samir Morsli et al. · Cancer Cell · 2023 · 234 citations · Full text

, , +16

HALO-109–301: a Phase III trial of PEGPH20 (with Pemcitabine and Nab-Paclitaxel) in Hyaluronic Acid-High Stage IV Pancreatic Cancer

Gary J. Doherty, Margaret A. Tempero, Pippa Corrie · Future Oncology · 2017 · 155 citations

, , +17

1–5 of 28